ACE inhibitors
Charlotte Nicholls Senior Pharmaceutical Technician (Special Projects Manager)
Mojgan Sani Consultant Pharmacist, Cardiothoracic Centre, Guys & St Thomas’s Hospital, University of Bath
In the fourth of this series on drugs and therapeutics, Charlotte Nicholls and Mojgan Sani discuss the use of ACE inhibitors, used to treat hypertension and heart failure
The development of angiotensin converting enzyme (ACE) inhibitors arose from the discovery of converting enzyme inhibitors in the venom of the South American pit viper (Bothrops jararaca). Through the study of these inhibitors, compounds were developed which bound to the site of ACE and inactivated the enzyme (Ondetti and Cushman 1982). These compounds led to the creation of a class of drugs known as ACE inhibitors, which are now used as effective anti-hypertensives and as part of therapy in heart failure.
Nursing Older People.
16, 2, 29-30.
doi: 10.7748/nop2004.04.16.2.29.c2304
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more